WI Harper Group backed Appier goes public on Tokyo Stock Exchange

[vc_row][vc_column][vc_column_text]WI Harper Group | March 30, 2020[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1617129356223{background-color: #e4e4e4 !important;}”]On March 30, 2021, Appier successfully listed on the Mothers Board, Tokyo Stock Exchange in Japan (Stock code: 4180). Appier is not only recognized as one of Taiwan first unicorns but also the first company to list in Japan since Trend Micro in 1998.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_single_image source=”external_link” external_img_size=”500×250″ alignment=”center” custom_src=”https://wiharper.com/wp-content/uploads/2021/03/Appier-1.jpg”][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]WI Harper Group co-led Appier’s Series B2 round in 2016 through WI Harper Fund VIII and Alibaba Taiwan Entrepreneurs Fund II. Appier has raised US$162 million in funding from investors including Sequoia, UOB, JAFCO, MediaTek, Softbank, EDB Investment, LINE, TGVest Capital, HOPU-Arm Innovation Fund, Pavilion Capital, and UMC Capital etc. The lead underwriters are SMBC Nikko Securities Inc. and Mizuho Securities Co., Ltd.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]Established in 2012 and headquarter in Taiwan, Appier focuses on cross device marketing solutions leveraging AI to help advertisers better understand and target their users. They are a partner to some of the world’s leading brands while providing a suite of enterprise-grade products to support data-driven decisions and accelerate business growth.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_single_image source=”external_link” external_img_size=”600×300″ alignment=”center” custom_src=”https://wiharper.com/wp-content/uploads/2021/03/Appier-2.png”][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]Japan’s market has become a hotbed for startups in recent years as its markets and corporations push boundaries to seek innovation. WI Harper Group has ambitious plans for Japan as part of our core North Asia strategy. With the success of Appier’s IPO, we will continue to support Japan and introduce exciting companies to the Japanese market.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space height=”50px”][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

| About Appier

Appier helps businesses solve their most challenging problems with artificial intelligence. It is a partner to some of the world’s leading brands, providing a suite of enterprise-grade products to support data-driven decisions and accelerate business growth. Established in 2012 by a passionate team of computer scientists and engineers, Appier now has more than 400 people across 14 offices and is recognized as a Top 50 AI company by Fortune Magazine. Learn more at www.appier.com.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

| About WI Harper Group:

 

WI Harper is a pioneer and leading cross-border venture capital firm investing in early and expansion stage companies globally. With offices in San Francisco, Beijing, and Taipei, the firm actively oversees more than $1 billion in assets under management. Since inception nearly three decades ago, WI Harper has invested in over 400 startups and has successfully experienced more than 100 IPO and M&A exits.

We look for innovative companies and visionary founders in healthcare, technology and sustainability fields where there are high synergies and meaningful value added cross selling opportunities. While our healthcare team is presently honing on bioinformatics and digital biology, our technology team is focused blockchain, big data, analytics, artificial intelligence, AR/VR, IoT, robotics, drones, autonomous driving, as well as digital media and green energy projects.

[/vc_column_text][/vc_column][/vc_row]

WI Harper Group backed Appier goes public on Tokyo Stock Exchange

Resvent Medical is a Shenzhen, China-based medical device and solution company focused on medical respiration & ventilation field, with its core management team having spun out of Mindray’s hospitals respiratory division, with over a decade of experience in homecare devices, clinical respiratory healthcare, intelligent information system, related consumable & accessories and value added services, and capable of building a globally competitive respiratory player – i.e. the RESMED of China.